Main Session
Sep
29
EDU 43 - Contemporary Management of High-Risk Cutaneous Squamous Cell Carcinoma: Evidence-Based Integration of Adjuvant Immunotherapy and Radiotherapy
Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Carcinoma: Translating Phase III Evidence Into Clinical Practice
Presenter(s)
Ann Silk, MD, MS - Dana-Farber Cancer Institute, Boston, MA